[Prevention of thrombophilic states by prolonged activation of fibrinolysis].
D000085:Acetates / Q000494:pharmacology; D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D002087:Butyrates / Q000494:pharmacology; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology*; D006496:Heparinoids / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D011817:Rabbits; D013927:Thrombosis / Q000517:prevention & control*
D000085:Acetates; D000924:Anticholesteremic Agents; D002087:Butyrates; D005343:Fibrinolytic Agents; D006496:Heparinoids; D009539:Nicotinic Acids; D011725:Pyridines; D006493:Heparin; D009526:Nialamide
Prophylaxie des états thrombophiliques par activation prolongée de la fibrinolyse.